ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTAntimalarials in Development in 2014David S. Barnett and R. Kiplin Guy*View Author Information Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, United States*E-mail: [email protected]Cite this: Chem. Rev. 2014, 114, 22, 11221–11241Publication Date (Web):October 23, 2014Publication History Received25 September 2014Published online23 October 2014Published inissue 26 November 2014https://pubs.acs.org/doi/10.1021/cr500543fhttps://doi.org/10.1021/cr500543freview-articleACS PublicationsCopyright © 2014 American Chemical SocietyRequest reuse permissionsArticle Views3658Altmetric-Citations64LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Bioavailability,Infectious diseases,Inhibition,Parasites,Rodent models Get e-Alerts
No takes yet. Share an insight, caveat, or question.
Barnett et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: